First Defense®
Prevention of Enteric Colibacillosis (Calf Scours)
CommercialMarketed
Key Facts
Indication
Prevention of Enteric Colibacillosis (Calf Scours)
Phase
Commercial
Status
Marketed
Company
About ImmuCell
ImmuCell Corporation (NASDAQ: ICCC) is a vertically integrated animal health biotech focused on developing and manufacturing products to combat costly production diseases in cattle. Its mission is to deliver scientifically advanced, economically valuable solutions to dairy and beef producers, exemplified by its commercial product First Defense® and its pivotal-stage candidate, Re-Tain™. The company's strategy centers on maintaining full control over its value chain from its Portland, Maine facility, targeting niche indications with high unmet need to secure sustainable growth within the robust animal health market.
View full company profile